Themis Medicare

17
Strong Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE083B01024
  • NSEID: THEMISMED
  • BSEID: 530199
INR
105.79
-0.66 (-0.62%)
BSENSE

Dec 05

BSE+NSE Vol: 41.99 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Themis Medicare Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
39.00
53.00
72.00
95.00
41.00
26.00
Adjustment
10.00
-1.00
0.00
0.00
7.00
9.00
Changes In working Capital
-5.00
-20.00
-40.00
-42.00
7.00
-35.00
Cash Flow after changes in Working Capital
45.00
31.00
32.00
52.00
56.00
0.00
Cash Flow from Operating Activities
34.00
22.00
16.00
34.00
56.00
0.00
Cash Flow from Investing Activities
-12.00
-15.00
-23.00
-15.00
-15.00
-5.00
Cash Flow from Financing Activities
-25.00
-8.00
0.00
-17.00
-25.00
6.00
Net Cash Inflow / Outflow
-3.00
-2.00
-7.00
1.00
15.00
1.00
Opening Cash & Cash Equivalents
9.00
12.00
20.00
19.00
3.00
1.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
6.00
9.00
12.00
20.00
19.00
3.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Themis Medicare
Markets Mojo
Figures in Cr
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Profit Before Tax
39.67
109.19
-70.00
-63.67%
Adjustment
10.89
0.96
10.00
1034.38%
Changes In working Capital
-5.11
9.17
-14.00
-155.73%
Cash Flow after changes in Working Capital
45.46
119.32
-74.00
-61.90%
Cash Flow from Operating Activities
34.71
93.02
-59.00
-62.69%
Cash Flow from Investing Activities
-12.17
-78.95
66.00
84.59%
Cash Flow from Financing Activities
-25.9
-6.4
-19.00
-304.69%
Net Cash Inflow / Outflow
-3.36
7.67
-10.00
-143.81%
Opening Cash & Cash Equivalents
9.92
5.75
4.00
72.52%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
6.56
13.41
-7.00
-51.08%
Cash Flow - Snapshot (Consolidated) - Mar'25
stock-summary

YoY Growth in year ended Mar 2025 is 57.13% vs 37.29% in Mar 2024

Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
34.71
22.09
57.13%